SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-15-050880
Filing Date
2015-07-13
Accepted
2015-07-13 17:12:35
Documents
1
Group Members
MONTREUX EQUITY PARTNERS V, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a15-15605_1sc13da.htm SC 13D/A 218343
  Complete submission text file 0001104659-15-050880.txt   220173
Mailing Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116 (617) 600-3497
EPIRUS Biopharmaceuticals, Inc. (Subject) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81444 | Film No.: 15985992
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
MONTREUX EQUITY PARTNERS IV LP (Filed by) CIK: 0001423641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA
Type: SC 13D/A